Tafinlar (Dabrafenib) and Mekinist (Trametinib) Combination Therapy

An oral BRAF and MEK inhibitor combination therapy for unresectable or advanced melanoma with BRAF V600E or V600K mutations.

If you have a Hayes login, click here to view the full report on the Knowledge Center.